4.5 Review

Strategies for the prevention of knee osteoarthritis

期刊

NATURE REVIEWS RHEUMATOLOGY
卷 12, 期 2, 页码 92-101

出版社

NATURE PORTFOLIO
DOI: 10.1038/nrrheum.2015.135

关键词

-

资金

  1. Bioventus
  2. Merck Sharp and Dohme
  3. Nicox
  4. Q-MED
  5. Bioberica
  6. Roche
  7. Servier

向作者/读者索取更多资源

Osteoarthritis (OA) has been thought of as a disease of cartilage that can be effectively treated surgically at severe stages with joint arthroplasty. Today, OA is considered a whole-organ disease that is amenable to prevention and treatment at early stages. OA develops slowly over 10-15 years, interfering with activities of daily living and the ability to work. Many patients tolerate pain, and many health-care providers accept pain and disability as inevitable corollaries of OA and ageing. Too often, health-care providers passively await final 'joint death', necessitating knee and hip replacements. Instead, OA should be viewed as a chronic condition, where prevention and early comprehensive-care models are the accepted norm, as is the case with other chronic diseases. Joint injury, obesity and impaired muscle function are modifiable risk factors amenable to primary and secondary prevention strategies. The strategies that are most appropriate for each patient should be identified, by selecting interventions to correct-or at least attenuate-OA risk factors. We must also choose the interventions that are most likely to be acceptable to patients, to maximize adherence to-and persistence with-the regimes. Now is the time to begin the era of personalized prevention for knee OA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据